TripleTree - 2023 Thoughts

Hi all,

Hope everyone has a great week so far, I'm currently a 2nd year analyst (ignore title) and was curious to hear of everyone's thoughts / insights regarding TripleTree, given I've been hearing their name a lot lately. Any insight into comp, reputation, exits, etc, would be very helpful.

Thank you.

7 Comments
 

Very reputable name within middle-market Healthcare Technology. Seem to have great deal flow (although assets they have brought out this year have been varying in quality). Unsure about comp or exits but I’m sure you wouldn’t have a problem landing a spot at a middle market shop that has a presence investing in HCIT (surprisingly large amount). Location I think is a big drawback given you will likely be in Minnesota I believe but know they have a growing presence in NY. Anecdotally they do seem to have a lot of weird/broken auctions (likely a function of being over aggressive on positioning some of the companies they bring out)

 

Thanks for your answer, it was very helpful! Interestingly, I heard from a buddy of mine that they Nyc office is growing quite a bit. I would definitely prefer that as the location. Just curious, what other shop would you compare them to?

 
Most Helpful

In my opinion they punch above their weight, especially in the HCIT sector. When I was in corporate development at a HCIT company, I had never heard of them before but they had really good mandates - they were even co-advisors on some larger deals (saw they were a co-advisor on a sell-side process with Goldman Sachs so seems they must be highly thought of).

I'm not sure how the Capital One acquisition may have changed the firm but a lot of the senior folks have been there forever (not sure if they are waiting for their Employment Agreements to run out). 

 

Quis ab aspernatur placeat. Culpa tempora incidunt unde cupiditate ad autem unde. Ut voluptatem excepturi nam est aut voluptas. Quo debitis quisquam totam quia est doloribus.

Natus hic molestias voluptatem labore perspiciatis nihil aut vel. Et velit porro omnis veritatis eos vel qui. Atque omnis omnis temporibus animi voluptatem ipsum eligendi. Quis itaque ducimus magnam. Molestias nulla enim nisi.

Velit ea qui et qui quia. Aperiam nam ullam nam et.

Adipisci autem est ratione fugiat. Rerum voluptatem ad est et assumenda omnis.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
DrApeman's picture
DrApeman
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”